Literature DB >> 22229890

Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity.

Hartmut Jaeschke1, Mitchell R McGill, Anup Ramachandran.   

Abstract

Hepatotoxicity is a serious problem during drug development and for the use of many established drugs. For example, acetaminophen overdose is currently the most frequent cause of acute liver failure in the United States and Great Britain. Evaluation of the mechanisms of drug-induced liver injury indicates that mitochondria are critical targets for drug toxicity, either directly or indirectly through the formation of reactive metabolites. The consequence of these modifications is generally a mitochondrial oxidant stress and peroxynitrite formation, which leads to structural alterations of proteins and mitochondrial DNA and, eventually, to the opening of mitochondrial membrane permeability transition (MPT) pores. MPT pore formation results in a collapse of mitochondrial membrane potential and cessation of adenosine triphosphate synthesis. In addition, the release of intermembrane proteins, such as apoptosis-inducing factor and endonuclease G, and their translocation to the nucleus, leads to nuclear DNA fragmentation. Together, these events trigger necrotic cell death. Alternatively, the release of cytochrome c and other proapoptotic factors from mitochondria can promote caspase activation and apoptotic cell death. Drug toxicity can also induce an inflammatory response with the formation of reactive oxygen species by Kupffer cells and neutrophils. If not properly detoxified, these extracellularly generated oxidants can diffuse into hepatocytes and trigger mitochondrial dysfunction and oxidant stress, which then induces MPT and necrotic cell death. This review addresses the formation of oxidants and the defense mechanisms available for cells and applies this knowledge to better understand mechanisms of drug hepatotoxicity, especially acetaminophen-induced liver injury.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22229890      PMCID: PMC5319847          DOI: 10.3109/03602532.2011.602688

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  220 in total

Review 1.  Mitochondrial abnormalities--a link to idiosyncratic drug hepatotoxicity?

Authors:  Urs A Boelsterli; Priscilla L K Lim
Journal:  Toxicol Appl Pharmacol       Date:  2006-12-22       Impact factor: 4.219

2.  Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration.

Authors:  J M Burgunder; A Varriale; B H Lauterburg
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 3.  Oxidative stress as a mechanism of valproic acid-associated hepatotoxicity.

Authors:  Thomas K H Chang; Frank S Abbott
Journal:  Drug Metab Rev       Date:  2006       Impact factor: 4.518

4.  Comparison of covalent binding of acetaminophen and the regioisomer 3'-hydroxyacetanilide to mouse liver protein.

Authors:  A M Matthews; J A Hinson; D W Roberts; N R Pumford
Journal:  Toxicol Lett       Date:  1997-01-15       Impact factor: 4.372

5.  Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities.

Authors:  Michie M K Ong; Calivarathan Latchoumycandane; Urs A Boelsterli
Journal:  Toxicol Sci       Date:  2006-12-05       Impact factor: 4.849

Review 6.  Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury.

Authors:  Hartmut Jaeschke; John J Lemasters
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

7.  Evidence for participation of lipid peroxidation and iron in diquat-induced hepatic necrosis in vivo.

Authors:  C V Smith
Journal:  Mol Pharmacol       Date:  1987-09       Impact factor: 4.436

8.  Calpain released from dying hepatocytes mediates progression of acute liver injury induced by model hepatotoxicants.

Authors:  Pallavi B Limaye; Udayan M Apte; Kartik Shankar; Thomas J Bucci; Alan Warbritton; Harihara M Mehendale
Journal:  Toxicol Appl Pharmacol       Date:  2003-09-15       Impact factor: 4.219

9.  Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N-acetylcysteine.

Authors:  Chieko Saito; Claudia Zwingmann; Hartmut Jaeschke
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

10.  Acetaminophen-induced cytotoxicity in cultured mouse hepatocytes: effects of Ca(2+)-endonuclease, DNA repair, and glutathione depletion inhibitors on DNA fragmentation and cell death.

Authors:  W Shen; L M Kamendulis; S D Ray; G B Corcoran
Journal:  Toxicol Appl Pharmacol       Date:  1992-01       Impact factor: 4.219

View more
  256 in total

1.  Establishment of a mouse model of enalapril-induced liver injury and investigation of the pathogenesis.

Authors:  Yuji Shirai; Shingo Oda; Sayaka Makino; Koichi Tsuneyama; Tsuyoshi Yokoi
Journal:  Lab Invest       Date:  2017-03-06       Impact factor: 5.662

2.  Mitochondrial Homeostasis in Acute Organ Failure.

Authors:  L Jay Stallons; Jason A Funk; Rick G Schnellmann
Journal:  Curr Pathobiol Rep       Date:  2013-09

Review 3.  Acetaminophen: Dose-Dependent Drug Hepatotoxicity and Acute Liver Failure in Patients.

Authors:  Hartmut Jaeschke
Journal:  Dig Dis       Date:  2015-07-06       Impact factor: 2.404

Review 4.  Role of autophagy in alcohol and drug-induced liver injury.

Authors:  Jessica A Williams; Wen-Xing Ding
Journal:  Food Chem Toxicol       Date:  2019-12-23       Impact factor: 6.023

5.  Toll-like receptor 4 blocker as potential therapy for acetaminophen-induced organ failure in mice.

Authors:  Mohamed Salama; Mohamed Elgamal; Azza Abdelaziz; Moataz Ellithy; Dina Magdy; Lina Ali; Emad Fekry; Zinab Mohsen; Mariam Mostafa; Hoda Elgamal; Hussein Sheashaa; Mohamed Sobh
Journal:  Exp Ther Med       Date:  2015-04-22       Impact factor: 2.447

6.  Oxidative Stress and Acute Hepatic Injury.

Authors:  Anup Ramachandran; Hartmut Jaeschke
Journal:  Curr Opin Toxicol       Date:  2018-02

7.  Aldehyde dehydrogenase-2 activation decreases acetaminophen hepatotoxicity by prevention of mitochondrial depolarization.

Authors:  Hereward J Wimborne; Jiangting Hu; Kenji Takemoto; Nga T Nguyen; Hartmut Jaeschke; John J Lemasters; Zhi Zhong
Journal:  Toxicol Appl Pharmacol       Date:  2020-03-30       Impact factor: 4.219

8.  Mitochondrial dysfunction and apoptosis underlie the hepatotoxicity of perhexiline.

Authors:  Zhen Ren; Si Chen; Ji-Eun Seo; Xiaoqing Guo; Dongying Li; Baitang Ning; Lei Guo
Journal:  Toxicol In Vitro       Date:  2020-08-28       Impact factor: 3.500

9.  Editor's Highlight: Metformin Protects Against Acetaminophen Hepatotoxicity by Attenuation of Mitochondrial Oxidant Stress and Dysfunction.

Authors:  Kuo Du; Anup Ramachandran; James L Weemhoff; Hemantkumar Chavan; Yuchao Xie; Partha Krishnamurthy; Hartmut Jaeschke
Journal:  Toxicol Sci       Date:  2016-08-25       Impact factor: 4.849

10.  Acetaminophen hepatotoxicity in mice: Effect of age, frailty and exposure type.

Authors:  Alice E Kane; Sarah J Mitchell; John Mach; Aniko Huizer-Pajkos; Catriona McKenzie; Brett Jones; Victoria Cogger; David G Le Couteur; Rafael de Cabo; Sarah N Hilmer
Journal:  Exp Gerontol       Date:  2015-11-23       Impact factor: 4.032

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.